Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ12661267-0,86
KB103710380,10
PKN82,8782,880,15
Msft516,12517,20,24
IBM255,85256,341,05
Mercedes-Benz Group AG51,4851,490,31
PFE24,0124,020,63
16.09.2025 14:06:08
Indexy online
AD Index online
select
AD Index online
 

  • 30.06.2025 21:09:30
Cochlear Ltd (COH.F, Frankfurt)
Poslední obchod Změna (%) Změna (EUR) Objem obchodů (EUR)
168,66 -0,50 -0,86 1 687
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace:
Popis společnosti
Obecné informace
Název společnostiCochlear Ltd
TickerCOH
Kmenové akcie:Fully Paid Ord. Shrs
RICCOH.AX
ISINAU000000COH5
Poslední známé roční výsledky30.06.2025
Poslední známé čtvrtletní výsledky30.06.2025
Počet zaměstnanců k 30.06.2025 5 500
Akcie v oběhu k 30.06.2025 65 397 004
MěnaAUD
Kontaktní informace
Ulice1 University Avenue
MěstoSYDNEY
PSČ2109
ZeměAustralia
Kontatní osoba 
Funkce kontaktní osoby 
Telefon61 294 286 555
Fax61294286352

Business Summary: Cochlear Limited provides implantable hearing solutions and a range of implants and sound processor upgrades. Its segments include Cochlear Implants, Services, and Acoustics. Cochlear Implants segment offers Cochlear implant systems. Services segment offers sound processor upgrades, accessories and other. Acoustics segment offers bone conduction systems and sound processor upgrades. Its products and services portfolio include Cochlear implant portfolio, Acoustic solutions portfolio, Recipient support tools, and Cochlear Connected Care solutions. Its Cochlear Connected Care solutions include Cochlear Nucleus SmartNav System, Cochlear Custom Sound Pro Fitting Software, Cochlear Link, Cochlear Remote Assist, and Cochlear Remote Check. Its Cochlear implant portfolio includes Cochlear Nucleus System. Acoustic solutions portfolio includes Cochlear Osia System, and Cochlear Baha System. Its Recipient support tools include Cochlear Nucleus, Baha and Osia Smart Apps and Cochlear CoPilot App.
Financial Summary: BRIEF: For the fiscal year ended 30 June 2025, Cochlear Ltd revenues increased 5% to A$2.34B. Net income increased 9% to A$388.9M. Revenues reflect Asia Pacific segment increase of 15% to A$428.8M, EMEA segment increase of 6% to A$789.7M, Asia Pacific segment increase of 15% to A$428.8M, EMEA segment increase of 6% to A$789.7M. Net income benefited from Integration costs decrease from A$28.2M (expense) to A$0K.
Odvětvová klasifikace
TRBC2009Advanced Medical Equipment
TRBC2012Medical Prosthetics
RBSS2004Advanced Medical Equipment
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICS2007Electromedical Apparatus Mfg
NAICS1997Electromedical and Electrotherapeutic Apparatus Manufacturing
SICElectromedical Equipment



  • Poslední aktualizace:
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Chief Executive Officer, Executive DirectorDiggory Howitt5603.01.2018
Chief Financial OfficerSarah Thom-01.01.202501.01.2025
President - North AmericaLisa Aubert-01.04.202201.04.2022
President - Europe, Middle East and Africa (EMEA)Anthony Bishop-01.01.202528.07.2016
President, Asia Pacific & Latin AmericaStuart Sayers-01.01.2025
Senior Vice President - Global Strategic MarketingDean Phizacklea-28.07.201628.07.2016
Senior Vice President - Global Supply ChainGreg Bodkin-
Senior Vice President- Global People and CultureJennifer Hornery-01.01.2017
Senior Vice President- Global Clinical Strategy, InnovationBrian Kaplan-01.01.2019
Chief Technology OfficerJan Janssen-01.10.2017